CELC
Price
$13.86
Change
+$0.08 (+0.58%)
Updated
Jul 16 closing price
Capitalization
524.83M
21 days until earnings call
COGT
Price
$11.86
Change
+$0.36 (+3.13%)
Updated
Jul 16 closing price
Capitalization
1.65B
26 days until earnings call
Interact to see
Advertisement

CELC vs COGT

Header iconCELC vs COGT Comparison
Open Charts CELC vs COGTBanner chart's image
Celcuity
Price$13.86
Change+$0.08 (+0.58%)
Volume$296.53K
Capitalization524.83M
Cogent Biosciences
Price$11.86
Change+$0.36 (+3.13%)
Volume$2.38M
Capitalization1.65B
CELC vs COGT Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. COGT commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and COGT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (CELC: $13.86 vs. COGT: $11.86)
Brand notoriety: CELC and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 118% vs. COGT: 76%
Market capitalization -- CELC: $524.83M vs. COGT: $1.65B
CELC [@Biotechnology] is valued at $524.83M. COGT’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CELC and COGT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish while COGT’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 4 bullish, 4 bearish.
  • COGT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CELC and COGT are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а +2.59% price change this week, while COGT (@Biotechnology) price change was +14.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

Reported Earning Dates

CELC is expected to report earnings on Nov 17, 2025.

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.65B) has a higher market cap than CELC($525M). COGT YTD gains are higher at: 52.051 vs. CELC (5.882). CELC has higher annual earnings (EBITDA): -114.96M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. CELC (206M). COGT has less debt than CELC: COGT (17.1M) vs CELC (98.7M). CELC (0) and COGT (0) have equivalent revenues.
CELCCOGTCELC / COGT
Capitalization525M1.65B32%
EBITDA-114.96M-284.04M40%
Gain YTD5.88252.05111%
P/E RatioN/AN/A-
Revenue00-
Total Cash206M246M84%
Total Debt98.7M17.1M577%
FUNDAMENTALS RATINGS
CELC vs COGT: Fundamental Ratings
CELC
COGT
OUTLOOK RATING
1..100
2331
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
7951
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (52) in the Miscellaneous Commercial Services industry is in the same range as COGT (84) in the Miscellaneous industry. This means that CELC’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (51) in the Miscellaneous industry is in the same range as CELC (79) in the Miscellaneous Commercial Services industry. This means that COGT’s stock grew similarly to CELC’s over the last 12 months.

CELC's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as COGT (99) in the Miscellaneous industry. This means that CELC’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (35) in the Miscellaneous industry is in the same range as CELC (43) in the Miscellaneous Commercial Services industry. This means that COGT’s stock grew similarly to CELC’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that COGT’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCCOGT
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 23 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLGJX10.53N/A
N/A
Principal LargeCap Growth I J
MAPLX28.25N/A
N/A
Morgan Stanley Inst Advantage L
FAFCX34.60N/A
N/A
Fidelity Advisor Financials C
JMVCX15.42N/A
N/A
Janus Henderson Mid Cap Value C
RLSFX14.54N/A
N/A
RiverPark Long/Short Opportunity Retail

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with IMNM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+0.58%
IMNM - CELC
45%
Loosely correlated
+15.12%
ABOS - CELC
45%
Loosely correlated
+5.34%
COGT - CELC
44%
Loosely correlated
+3.13%
RXRX - CELC
44%
Loosely correlated
+3.26%
RAPP - CELC
44%
Loosely correlated
+5.84%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+3.13%
SPHDF - COGT
63%
Loosely correlated
N/A
ATXS - COGT
52%
Loosely correlated
+0.32%
IDYA - COGT
50%
Loosely correlated
+3.36%
XNCR - COGT
50%
Loosely correlated
+4.62%
CGON - COGT
49%
Loosely correlated
+4.53%
More